David Hodson
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 1
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Anna D. Staniszewska (2 shared papers)Kayode Ogungbenro (3 shared papers)Michael Davies (3 shared papers)Elaine Cadogan (1 shared paper)Hitesh Mistry (4 shared papers)Leon Aarons (3 shared papers)James Yates (3 shared papers)Paul Farrington (2 shared papers)
- Journals
- CPT Pharmacometrics & Systems Pharmacology (1 paper)Molecular Cancer Therapeutics (1 paper)European Journal of Pharmaceutical Sciences (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United KingdomSingaporeUnited States
In The Last Decade
David Hodson
3 papers receiving 10 citations
Peers
Comparison fields: 5 of 11
- Oncology 6
- Immunology 4
- Genetics 1
- Analytical Chemistry 1
- Cancer Research 1
Countries citing papers authored by David Hodson
This map shows the geographic impact of David Hodson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hodson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hodson more than expected).
Fields of papers citing papers by David Hodson
This network shows the impact of papers produced by David Hodson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hodson. The network helps show where David Hodson may publish in the future.
Co-authors
The 12 scholars most cited alongside David Hodson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2025 | 0 |
About David Hodson
David Hodson is a scholar working on Oncology, Immunology, Surgery, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 4 papers that have together received 10 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (2 papers), CAR-T cell therapy research (1 paper), Radiation Therapy and Dosimetry (1 paper), Advances in Oncology and Radiotherapy (1 paper) and Bladder and Urothelial Cancer Treatments (1 paper). The work is most often cited by research in Oncology (6 citations), Immunology (4 citations), Genetics (1 citation), Analytical Chemistry (1 citation) and Cancer Research (1 citation). David Hodson has collaborated with scholars based in United Kingdom, Singapore and United States. Frequent co-authors include Anna D. Staniszewska, Kayode Ogungbenro, Michael Davies, Elaine Cadogan, Hitesh Mistry, Leon Aarons, James Yates, Paul Farrington, Michael M. Schmidt and Robert Tighe. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, Molecular Cancer Therapeutics, European Journal of Pharmaceutical Sciences and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.